HOME >> BIOLOGY >> NEWS
First confirmed common genetic risk factors for breast cancer

The most powerful genetic analysis of the DNA codes of over 40,000 women -- including those with breast cancer as well as those without the disease has uncovered five common genetic variants that increase an individuals risk for breast cancer.

In a paper published online today in the journal Nature, the international team of scientists who conducted the genome-wide association study report that these five genes code for proteins crucial to biological activities that previously had not been implicated as triggers of breast cancer. The genes carry the DNA recipes for proteins important to the growth and duplication of body cells and the signalling, or communications, that must occur between cells in order for the body to function normally.

Previous investigations have identified about a dozen genetic mutations associated with breast cancer susceptibility. Normal versions of these genes help prevent cancer from occurring in the first place, by helping cells to repair DNA breaks and other abnormalities that can result from chance or exposure to an environmental toxin, such as excessive UV sunlight. However, BRCA-1, BRCA-2 and the other previously identified breast cancer susceptibility genes are mutated in a relatively small percentage of women.

"Risk mutations within these genes are so rare that only a very small number of breast cancer incidences are caused by these mutations," said Jianjun Liu, Ph.D., co-author of the Nature paper and Senior Research Scientist at the Genome Institute of Singapore, one of the over 20 research institutions collaborating in the international study of breast cancer genes.

The five genetic variants identified by Dr. Liu and collaborators occur more frequently among women with breast cancer than do BRCA and the other previously identified breast cancer susceptibility genes.

The five genes are the FGFR2, TNRC9/ LOC643714, MAP3K1, and LSP1.

"This is a truly landmark breakthro
'"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
Agency for Science, Technology and Research (A*STAR), Singapore
27-May-2007


Page: 1 2

Related biology news :

1. First case of successful ovarian tissue transplantation between two, nonidentical sisters
2. First new multiple sclerosis gene found in 30 years
3. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
4. First all-African produced genetically engineered maize is resistant to maize streak virus
5. First baby is born after oocytes were matured in the lab and frozen
6. First demonstration of new hair follicle generation in an animal model
7. First research to show that diabetes damages DNA in mens sperm and may affect fertility
8. First demonstration of muscle restoration in an animal model of Duchenne muscular dystrophy
9. First systematic study of Chinas one-child policy reveals complexity, effectiveness
10. First international conference on self-healing materials
11. First impressions: Computer model behaves like humans on visual categorization task

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/3/2018)... ... October 03, 2018 , ... Fit4D, ... the appointment of healthcare visionary, Jimmy Lee, as Strategic Advisor to the company’s ... of healthcare industry experience. As a Senior Executive at Anthem, he had P&L ...
(Date:10/2/2018)... ... ... a fun-loving eight-year-old Labrador retriever. Like many labs, Stuart’s favorite thing in the world ... much that whenever anyone comes to our door, he grabs a toy to greet them, ... 2017, Stuart began limping and eventually could no longer play fetch. Though he was ...
(Date:10/2/2018)... ... October 02, 2018 , ... As a leading ... Biosciences, The Cell Analysis Company , is excited to offer xCELLigence® RTCA ... design and data analysis for immune oncology researchers are now much easier, especially ...
Breaking Biology News(10 mins):
(Date:9/29/2018)... ... September 29, 2018 , ... Voxx ... early-stage companies to access the power of influence analytics and data-driven engagement decision ... a broader market that didn’t necessarily have access to the same financial resources ...
(Date:9/27/2018)... ... 2018 , ... Medable was named DPharm Idol at this ... human digitome, a digital representation of human health and disease, by removing the ... data sources. Dr. Michelle Longmire, Co-Founder and CEO of Medable, explained that their ...
(Date:9/22/2018)... ... September 20, 2018 , ... ... venture. The synergistic combination of Predicine’s GeneRADAR molecular insights platform with Flagship’s ... to empower clinical trials in the immuno-oncology (IO) space. , IO therapies ...
(Date:9/13/2018)... ... September 13, 2018 , ... Asymmetrex’s director, James ... would have gotten in medicine, if we didn’t have the means to measure the ... patients?” His answer, “Nowhere! And that is what’s holding up progress in stem ...
Breaking Biology Technology:
Cached News: